{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T09:04:59Z","timestamp":1648544699503},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,5,23]],"date-time":"2010-05-23T00:00:00Z","timestamp":1274572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00595-008-4091-1","type":"journal-article","created":{"date-parts":[[2010,5,22]],"date-time":"2010-05-22T08:37:05Z","timestamp":1274517425000},"page":"574-577","source":"Crossref","is-referenced-by-count":0,"title":["Advanced ampullary carcinoma showing complete response to S-1: Report of a case"],"prefix":"10.1007","volume":"40","author":[{"given":"Nobutsugu","family":"Abe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadahiko","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Atomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,23]]},"reference":[{"key":"4091_CR1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0959-8049(97)10166-6","volume":"34","author":"M. Hejna","year":"1998","unstructured":"Hejna M, Pruckmayer M, Raderer M. The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. Eur J Cancer 1998;34:977\u2013986.","journal-title":"Eur J Cancer"},{"key":"4091_CR2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/annonc\/mdh351","volume":"15","author":"T. Andr\u00e9","year":"2004","unstructured":"Andr\u00e9 T, Tournigand C, Rosmorduc O, Provent S, Maindrault-Goebel F, Avenin D, et al. Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol 2004;15:1339\u20131343.","journal-title":"Ann Oncol"},{"key":"4091_CR3","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/cncr.22902","volume":"15","author":"R.P. Riechelmann","year":"2007","unstructured":"Riechelmann RP, Townsley CA, Chin SN, Pond GR, Knox JJ. Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer. Cancer 2007;15:1307\u20131312.","journal-title":"Cancer"},{"key":"4091_CR4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00280-005-0095-3","volume":"57","author":"T. Okusaka","year":"2006","unstructured":"Okusaka T, Ishii H, Funakoshi A, Yamao K, Ohkawa S, Saito S, et al. Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol 2006;57:647\u2013653.","journal-title":"Cancer Chemother Pharmacol"},{"key":"4091_CR5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00595-007-3504-x","volume":"37","author":"N. Koide","year":"2007","unstructured":"Koide N, Suzuki A, Saito H, Sato T, Murakami M, Ota H, et al. Gastric small cell carcinoma successfully treated by surgery and postoperative chemotherapy consisting of cisplatin and S-1: report of a case. Surg Today 2007;37:989\u2013994.","journal-title":"Surg Today"},{"key":"4091_CR6","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S. Sakuramoto","year":"2007","unstructured":"Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007;357:1810\u20131820.","journal-title":"N Engl J Med"},{"key":"4091_CR7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000086771","volume":"68","author":"H. Ueno","year":"2005","unstructured":"Ueno H, Okusaka T, Ikeda M, Takezako Y, Morizane C. An early phase II study of S-1 in patients with metastatic pancreatic cancer. Oncology 2005;68:171\u2013178.","journal-title":"Oncology"},{"key":"4091_CR8","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/sj.bjc.6603735","volume":"96","author":"H. Shinchi","year":"2007","unstructured":"Shinchi H, Maemura K, Noma H, Mataki Y, Aikou T, Takao S. Phase-I trial of oral fluoropyrimidine anticancer agent (S-1) with concurrent radiotherapy in patients with unresectable pancreatic cancer. Br J Cancer 2007;96:1353\u20131357.","journal-title":"Br J Cancer"},{"key":"4091_CR9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00595-007-3656-8","volume":"38","author":"H. Sunagawa","year":"2008","unstructured":"Sunagawa H, Inamine S, Zaha H, Takeshima M, Miyata M. Advanced gastric carcinoma combined with extra-adrenal pheochromocytoma resected after three courses of S-1 and cisplatin as neoadjuvant chemotherapy: report of a case. Surg Today 2008;38:445\u2013448.","journal-title":"Surg Today"},{"key":"4091_CR10","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/sj.bjc.6602208","volume":"91","author":"H. Ueno","year":"2004","unstructured":"Ueno H, Okusaka T, Ikeda M, Takezako Y, Morizane C. Phase II study of S-1 in patients with advanced biliary tract cancer. Br J Cancer 2004;91:1769\u20131774.","journal-title":"Br J Cancer"},{"key":"4091_CR11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00280-007-0673-7","volume":"62","author":"J. Furuse","year":"2008","unstructured":"Furuse J, Okusaka T, Boku N, Ohkawa S, Sawaki A, Masumoto T, et al. S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study. Cancer Chemother Pharmacol 2008;62:849\u2013855.","journal-title":"Cancer Chemother Pharmacol"},{"key":"4091_CR12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00000658-199709000-00004","volume":"226","author":"C.J. Yeo","year":"1997","unstructured":"Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 1997;226:248\u2013257.","journal-title":"Ann Surg"},{"key":"4091_CR13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/jjco\/hym116","volume":"37","author":"N. Yonemoto","year":"2007","unstructured":"Yonemoto N, Furuse J, Okusaka T, Yamao K, Funakoshi A, Ohkawa S, et al. A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer. Jpn J Clin Oncol 2007;37:843\u2013851.","journal-title":"Jpn J Clin Oncol"},{"key":"4091_CR14","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000070622","volume":"49","author":"M.H. Lin","year":"2003","unstructured":"Lin MH, Chen JS, Chen HH, Su WC. A phase II trial of gemcitabine in the treatment of advanced bile duct and periampullary carcinomas. Chemotherapy 2003;49:154\u2013158.","journal-title":"Chemotherapy"},{"key":"4091_CR15","doi-asserted-by":"crossref","unstructured":"Ueno H, Furuse J, Yamao K, Funakoshi A, Boku N, Ohkawa S, et al. A multicenter phase II study of gemcitabine and S-1 combination therapy (GS therapy) in patients with metastatic pancreatic cancer. In: ASCO 2007 Gastrointestinal Cancers Symposium; 2007. Abstract No. 148.","DOI":"10.1200\/jco.2007.25.18_suppl.4550"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-008-4091-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-008-4091-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-008-4091-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T23:05:24Z","timestamp":1591311924000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-008-4091-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,23]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["4091"],"URL":"https:\/\/doi.org\/10.1007\/s00595-008-4091-1","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,23]]}}}